noma; others are rather rare. The mean age of patients at the diagnosis of vulvar carcinoma is 70 years.
Introduction
Vulvar carcinoma accounts for 4% of all gynecological cancers. The most frequent cancer type (90%) is squamous cell carciof >1 mm, treated with radical vulvectomy and inguinofemoral lymphadenectomy, is nearly 70%.
The most significant prognostic factor is the number of metastatic inguinofemoral lymph nodes.
Despite fairly high survival of patients, short-or long-term morbidities associated with the above mentioned radical surgical technique are worryingly high. These morbidities, which considerably prolong hospitalization, are infections, lymphocysts, scar dehiscence and lymphatic edema of the lower limbs.
A standard treatment modality applied in early stages of vulvar carcinoma (T1, tumor <2cm; T2, tumor >2cm), not accompanied by palpable inguinal lymph nodes enlargement, is extensive local excision of the tumour with the safety margin of 1 cm and uni-or bilateral inguinofemoral lymphadenectomy, both performed in two separate incisions. Postoperative radiotherapy is indicated if more than one node is metastatic.
In early stages of the disease, metastatic involvement of inguinofemoral lymph nodes is observed in 20-30% of patients. The rest of the patients (70%) do not benefit significantly from surgical intervention; however, a considerable increase in morbidity rates has been observed. Since the introduction of the technique with two separate incision sites, the number of complications decreased, though lymphoedema, lymphocysts or scar dehiscence are still fairly frequent.
No reliable method for determining the inguinofemoral nodes status has been so far developed. Palpation can detect just about 25% of all metastatic nodes. The results of ultrasound (US) and positron emission tomography (PET) examinations are unsatisfactory, whereas the potential of the computer tomography (CT) examination in the search of metastatic nodes has not been extensively described in the literature. The sensitivity of magnetic resonance imaging (MRI) was assessed to range between 40-50% and the specificity, between 90-100%. Among the most promising methods for detecting metastases in the regional nodes is US-guided fine-needle biopsy though, admittedly, it requires highly skilled operators in order to yield success and efficiency. 1 On account of so sparse non-invasive techniques for determining the inguinofemoral nodes status, of non-involved nodes in the majority of patients with a low stage vulvar carcinoma and on account of frequent morbidity following lymphadenectomy, there was an urgent need to develop a minimally invasive surgical technique for diagnosing vulvar carcinoma, i.e. sentinel lymph node detection (SLND).
Sentinel lymph node -what is it?
The sentinel lymph node is the first node in the lymphatic basin into which the lymph from the primary tumour is drained; histological examination of the sentinel lymph node is hypothetically representative for the rest of the nodes in the region. A histologically negative sentinel lymph node should be indicative for the absence of the metastases in all other non-sentinel nodes. 2 
Sentinel lymph node biopsy -when and how?
The sentinel lymph node biopsy should be performed in the patients in whom • vulvar carcinoma with the in-depth invasion of more than 1 mm was confirmed histologically, • injection of the necessary substances into the tumour surrounding is possible, and • no enlarged or fixed lymph nodes were detected in the inguinal region.
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Before the operation, the patient should be fully informed of the details of the examination, to what purpose the results of the examination would serve, how the examination would affect further treatment, and that the treatment is only experimental. The treatment can be started only after obtaining the informed consent signed by the patient.
The sentinel lymph node should always be marked in two ways, i.e. with 99m Tc (Technetium) labeled nanocolloid and with blue dye; this is the most reliable marking method assuring that the node will absolutely be found later. According to the literature, the injection of blue dye alone detects the sentinel node only in 56-88% of cases. 3 Given that the injection of nanocolloid is a painful procedure, it is recommended that an anaesthetic gel is applied to vulva before the injection; 4 at our Institute, we usually apply local anaesthetic cream EMLA.
Colloid is then injected with a fine needle at four separate injection sites alongside the peripheral tumour margin. Care should be taken that nanocolloid does not get spilled over the vulva or inguinal area because tiny radioactive particles detected by scintigraphy may compromise the image interpretation.
The patient is immediately transported to the isotope treatment unit where first a dynamic and then a static lymphoscintigraphies are performed by gamma camera. The first active and persistent spot found by this technique is sentinel node; its location is marked on the skin. Sometimes, two highly active sites may be found; in these cases, both are marked on the skin. 1 The blue dye is applied immediately before surgery. It is injected at four separate sites alongside the tumour margin. On the site marked on the skin incision, approximately 3-4 cm long, is made; the tissue is then carefully pushed aside in order to avoid severe haemorrhage that would obstruct the detection of the blue-dyed node. The node's activity is checked by portable gamma-ray detector. The node is then cautiously excised. If the next node is also dyed blue, it should be removed, too despite lower activity. If the carcinoma is located in the centre, the sentinel node on the other side should be removed, too. After sentinel lymph nodectomy, the excision of tumour with a wide safety margin should be performed. Radical vulvectomy is recommended only in cases of multifocal growth of the tumour.
The nodes excised during surgery may be sent to cytology laboratory for intraoperative evaluation of the samples by imprint cytology. The frozen section technique is not advised because it destroys the excised node completely so that no further examinations are possible. However, the surgeon may finish the operation a few days later after having received the results of the imprint cytology. If the results confirm metastatic involvement in the node, inguinofemoral lymphadenectomy or postoperative irradiation of the affected area should be performed; the decision between the two options depends on health condition of each patient and on other of prognostic factors.
Patients and methods
In 2003, in view of the data from the literature reporting a 100% negative prognostic value 3 we decided to apply a new method of treatment, i.e. removal of sentinel lymph nodes alone. Two hours before surgery, the patients were injected intradermally with 99m Tc nanocolloid in four quadrants lining the outer margins of the tumour. Static and also dynamic lymphoscintigraphies ( Figure 1 ) were then performed detecting active nodes and the locations were marked on the skin (Figure 2 ).
Before surgery, methylene blue dye was injected intradermally, too. The first five operations were performed under the supervision of an IAEA instructor.
During operation, sentinel nodes were detected by hand-held gamma probe. In all cases, we first excised the lymph nodes that were dyed blue and active and then the nodes that were not dyed, but still active. After the removal of the nodes, the tumour on the vulva was excised. In all surgical interventions, a conservative approach was followed, i.e. only the tumour with a wide safety margin was removed and not the entire vulva. In 19 cases, unilateral nodectomy was performed, whereas in 16 cases, nodectomy was bilateral.
Results

Metastatic nodes
Sentinel node biopsies were positive (SNB+) in 10 out of 35 patients (28.6%), which is consistents with the data from the literature. In 4 patients, the sentinel nodes were identified bilaterally, and in two cases, the nodes were metastatic on both sides. In all patients, postoperative care was normal, without serious complications.
In one patient, a cluster of clinically metastatic nodes was detected behind the positive sentinel node. Therefore, all nodes 
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down to the femoral canal were removed. The patient underwent also CT examination which detected that deeply seated pelvic lymph nodes were also metastatic.
In 3 patients, reoperation (inguinofemoral dissection) was required, and 9 were treated with postoperative irradiation. Six patients died of the disease spread; in 4 patients, the disease progressed into the inguinal area; in four patients, no evidence of disease was found. In one patient, local recurrence was observed 43 months after the completed therapy. Local excision was performed and the patient was also irradiated. The patient was without evidence of disease after 55 months (Table 1 ). 
Nodes without metastatic involvement
Sentinel node biopsies were negative (SNB-) in 25 out of 35 patients (71.4%). Postoperative complications were not observed; the patients were therefore dis- missed from the hospital 2 or 3 days after surgery. In three patients, recurrence in the inguinal region was detected 12, 24 and 26 months after the completed primary treatment, respectively. In one patient, the cause of the recurrence could be assigned to the inexperience of the surgeon; in the second, the node, next to the sentinel node, which was active, was not identified; and in the third patient, the active node did not show up because of a scar of an earlier operation in the inguinal region. By the end of 2007, 22 patients are alive, 21 of them with no evidence of disease (NED), one died with groin recurrence and lung metastases after 49 months, one died of other causes, and patient with melanoma malignum is alive with the disease (liver metastases) ( Table 2 ). One patient (N° 22) was lost in the follow up.
Discussion
The first who, as early as 1991, assumed that the superficial inguinal lymph nodes in vulvar carcinoma serve as sentinel nodes for the deep-lying ones was DiSaia et al. The first study dealing with this subject was published by Levenback et al in 1994. He and his team detected the sentinel nodes by using blue dye and verified the reliability of the method by complete inguinofemoral lymphadenectomy performed later on.
Three years later, deCesare published the results of his study made on intraoperative sentinel node detection by using a gamma-ray detector. Both methods were then merged by Hullu who used lymphoscintigraphy to mark the nodes preoperatively and the blue dye to detect them intraoperatively. 1 Both sentinel lymph node marking techniques are suitable; however, the best results are usually obtained by the combination of both. From the reported data, it is evident that the methods applying the combination of both yield a 100% success, whereas blue dye applied alone is successful in only 56-88% of cases. 5 
Conclusions
Sentinel node biopsy is a promising diagnostic tool in the evaluation of vulvar carcinoma and of node status as well as of disease stage. Due to low incidence of squamous cell carcinoma of the vulva, the experiences in the above treatment of this cancer are not so rich and the data in the literature are scarce; therefore, this treatment modality is applied more or less as an experimental method as it has not been yet approved as a standard method. In order to recognize the value of the obtained knowledge about the new treatment method and to confirm the efficiency or inefficiency of this method, further multicentre research studies need to be performed on larger randomized groups of patients.
